⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FATE News
Fate Therapeutics, Inc.
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
globenewswire.com
FATE
Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR
globenewswire.com
FATE
Fate Therapeutics to Participate in Upcoming Second Quarter 2026 Conferences
globenewswire.com
FATE
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE
Scalable Biotech Manufacturing Unlocks a $14B Market
prnewswire.com
MBRX
GUTS
IBRX
FATE
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
globenewswire.com
FBLG
FATE
MESO
LGVN
Syndigo Acquires Taggstar to Make Product Experiences Dynamic and Contextual
globenewswire.com
SJM
DOLE
SWK
CL
UL
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
FATE
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
prnewswire.com
FBLG
MESO
LGVN
FATE